The debate between those who favour investment in AIDS treatment and those who favour investment in its prevention came to the forefront Thursday at a U.S House of Representatives hearing on U.S. investments in HIV/AIDS in Africa.
The debate between those who favour investment in AIDS treatment and those who favour investment in its prevention came to the forefront Thursday at a U.S House of Representatives hearing on U.S. investments in HIV/AIDS in Africa.